|
COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 28,2000 PSA#2545DHHS/PHS/FDA/Office Of Facilities, Acquisition, And Central Services,
Division of Contracts and Program Management, HFA-512(COB), 5600
Fishers Lane, Rockville, MD 20857 B -- STUDY EFFECT OF A FLUOROQUINOLONE ANTIBIOTIC ON A CHEMOSTAT MODEL
SYSTEM. SOL V08508-00-00 DUE 031000 POC Trudy Dartouzos, ph:
301/827-7165; fax: 301/827-7103 See Notes 21 & 22. This announcement is
for information purposes only and will be made on a sole source basis
by COB 3/10/00. This award is a planned solicitation under the
simplified acquisition process. The Food and Drug Administration [FDA],
Center for Veterinary Medicine [CVM] intends to award a purchase order
to study the effect of fluoroquinolone antibiotic, ciprofloxacin, on
the barrier effect on a chemostat model system containing human
intestinal microflora. Period of Performance: 6 months from date of
award. A final report is due at the end of the 6 months to include
detailed results of the studies performed during the 6 month period.
Posted 02/24/00 (W-SN428085). (0055) Loren Data Corp. http://www.ld.com (SYN# 0010 20000228\B-0003.SOL)
B - Special Studies and Analyses - Not R&D Index Page
|
|